カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

メシル酸イマチニブAPIのグローバル市場2023：純度≧99%、純度<99%

■ 英語タイトル：Global Imatinib Mesylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG10771）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG10771
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医療機器＆消耗品
■ ページ数：123
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[メシル酸イマチニブAPIのグローバル市場2023：純度≧99%、純度<99%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、メシル酸イマチニブAPIのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界のメシル酸イマチニブAPI市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- メシル酸イマチニブAPIの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

メシル酸イマチニブAPI市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・純度≧99%、純度<99%

用途別セグメント
・錠剤、カプセル

主要な市場プレーヤー
・Aurobindo Pharma Ltd、Formosa Laboratories Inc、Cadila Healthcare Ltd、Laurus Labs Ltd、Msn Laboratories Private Ltd、Intas Pharmaceuticals Ltd、Zydus Lifesciences Ltd、Hetero Labs Ltd、Shilpa Pharma Lifesciences Ltd、Teva Pharmaceutical Industries Ltd、Cipla Ltd、Acebright India Pharma Private Ltd、Fis Fabbrica Italiana Sintetici Spa、Dr Reddys Laboratories Ltd、Natco Pharma Ltd、Sun Pharmaceutical Industries Ltd、Reliance Life Sciences Pvt Ltd、Zhejiang Jiuzhou Pharmaceutical Co Ltd、Tai Heng Industry Group Co Ltd、Shandong Anxin Pharmaceutical Co Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、メシル酸イマチニブAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なメシル酸イマチニブAPIメーカーの企業概要、2019年～2022年までのメシル酸イマチニブAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なメシル酸イマチニブAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別メシル酸イマチニブAPIの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのメシル酸イマチニブAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのメシル酸イマチニブAPI市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびメシル酸イマチニブAPIの産業チェーンを掲載しています。
・第14、15章では、メシル酸イマチニブAPIの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– メシル酸イマチニブAPIの概要
– 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99% - 用途別分析（2018年vs2022年vs2029年）：錠剤、カプセル - 世界のメシル酸イマチニブAPI市場規模・予測 - 世界のメシル酸イマチニブAPI生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Aurobindo Pharma Ltd、Formosa Laboratories Inc、Cadila Healthcare Ltd、Laurus Labs Ltd、Msn Laboratories Private Ltd、Intas Pharmaceuticals Ltd、Zydus Lifesciences Ltd、Hetero Labs Ltd、Shilpa Pharma Lifesciences Ltd、Teva Pharmaceutical Industries Ltd、Cipla Ltd、Acebright India Pharma Private Ltd、Fis Fabbrica Italiana Sintetici Spa、Dr Reddys Laboratories Ltd、Natco Pharma Ltd、Sun Pharmaceutical Industries Ltd、Reliance Life Sciences Pvt Ltd、Zhejiang Jiuzhou Pharmaceutical Co Ltd、Tai Heng Industry Group Co Ltd、Shandong Anxin Pharmaceutical Co Ltd ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：純度≧99%、純度<99% ・用途別分析2018年-2029年：錠剤、カプセル ・メシル酸イマチニブAPIの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・メシル酸イマチニブAPIのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・メシル酸イマチニブAPIのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・メシル酸イマチニブAPIの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・メシル酸イマチニブAPIの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Imatinib Mesylate API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Imatinib Mesylate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99% 1.4 Market Analysis by Application 1.4.1 Overview: Global Imatinib Mesylate API Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Tablet 1.4.3 Capsule 1.5 Global Imatinib Mesylate API Market Size & Forecast 1.5.1 Global Imatinib Mesylate API Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Imatinib Mesylate API Sales Quantity (2018-2029) 1.5.3 Global Imatinib Mesylate API Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Aurobindo Pharma Ltd 2.1.1 Aurobindo Pharma Ltd Details 2.1.2 Aurobindo Pharma Ltd Major Business 2.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services 2.1.4 Aurobindo Pharma Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Aurobindo Pharma Ltd Recent Developments/Updates 2.2 Formosa Laboratories Inc 2.2.1 Formosa Laboratories Inc Details 2.2.2 Formosa Laboratories Inc Major Business 2.2.3 Formosa Laboratories Inc Imatinib Mesylate API Product and Services 2.2.4 Formosa Laboratories Inc Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Formosa Laboratories Inc Recent Developments/Updates 2.3 Cadila Healthcare Ltd 2.3.1 Cadila Healthcare Ltd Details 2.3.2 Cadila Healthcare Ltd Major Business 2.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Product and Services 2.3.4 Cadila Healthcare Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Cadila Healthcare Ltd Recent Developments/Updates 2.4 Laurus Labs Ltd 2.4.1 Laurus Labs Ltd Details 2.4.2 Laurus Labs Ltd Major Business 2.4.3 Laurus Labs Ltd Imatinib Mesylate API Product and Services 2.4.4 Laurus Labs Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Laurus Labs Ltd Recent Developments/Updates 2.5 Msn Laboratories Private Ltd 2.5.1 Msn Laboratories Private Ltd Details 2.5.2 Msn Laboratories Private Ltd Major Business 2.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services 2.5.4 Msn Laboratories Private Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Msn Laboratories Private Ltd Recent Developments/Updates 2.6 Intas Pharmaceuticals Ltd 2.6.1 Intas Pharmaceuticals Ltd Details 2.6.2 Intas Pharmaceuticals Ltd Major Business 2.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services 2.6.4 Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Intas Pharmaceuticals Ltd Recent Developments/Updates 2.7 Zydus Lifesciences Ltd 2.7.1 Zydus Lifesciences Ltd Details 2.7.2 Zydus Lifesciences Ltd Major Business 2.7.3 Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services 2.7.4 Zydus Lifesciences Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Zydus Lifesciences Ltd Recent Developments/Updates 2.8 Hetero Labs Ltd 2.8.1 Hetero Labs Ltd Details 2.8.2 Hetero Labs Ltd Major Business 2.8.3 Hetero Labs Ltd Imatinib Mesylate API Product and Services 2.8.4 Hetero Labs Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Hetero Labs Ltd Recent Developments/Updates 2.9 Shilpa Pharma Lifesciences Ltd 2.9.1 Shilpa Pharma Lifesciences Ltd Details 2.9.2 Shilpa Pharma Lifesciences Ltd Major Business 2.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services 2.9.4 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Shilpa Pharma Lifesciences Ltd Recent Developments/Updates 2.10 Teva Pharmaceutical Industries Ltd 2.10.1 Teva Pharmaceutical Industries Ltd Details 2.10.2 Teva Pharmaceutical Industries Ltd Major Business 2.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services 2.10.4 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates 2.11 Cipla Ltd 2.11.1 Cipla Ltd Details 2.11.2 Cipla Ltd Major Business 2.11.3 Cipla Ltd Imatinib Mesylate API Product and Services 2.11.4 Cipla Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 Cipla Ltd Recent Developments/Updates 2.12 Acebright India Pharma Private Ltd 2.12.1 Acebright India Pharma Private Ltd Details 2.12.2 Acebright India Pharma Private Ltd Major Business 2.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services 2.12.4 Acebright India Pharma Private Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 Acebright India Pharma Private Ltd Recent Developments/Updates 2.13 Fis Fabbrica Italiana Sintetici Spa 2.13.1 Fis Fabbrica Italiana Sintetici Spa Details 2.13.2 Fis Fabbrica Italiana Sintetici Spa Major Business 2.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services 2.13.4 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates 2.14 Dr Reddys Laboratories Ltd 2.14.1 Dr Reddys Laboratories Ltd Details 2.14.2 Dr Reddys Laboratories Ltd Major Business 2.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services 2.14.4 Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.14.5 Dr Reddys Laboratories Ltd Recent Developments/Updates 2.15 Natco Pharma Ltd 2.15.1 Natco Pharma Ltd Details 2.15.2 Natco Pharma Ltd Major Business 2.15.3 Natco Pharma Ltd Imatinib Mesylate API Product and Services 2.15.4 Natco Pharma Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.15.5 Natco Pharma Ltd Recent Developments/Updates 2.16 Sun Pharmaceutical Industries Ltd 2.16.1 Sun Pharmaceutical Industries Ltd Details 2.16.2 Sun Pharmaceutical Industries Ltd Major Business 2.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services 2.16.4 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.16.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates 2.17 Reliance Life Sciences Pvt Ltd 2.17.1 Reliance Life Sciences Pvt Ltd Details 2.17.2 Reliance Life Sciences Pvt Ltd Major Business 2.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services 2.17.4 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.17.5 Reliance Life Sciences Pvt Ltd Recent Developments/Updates 2.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd 2.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Details 2.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business 2.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services 2.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates 2.19 Tai Heng Industry Group Co Ltd 2.19.1 Tai Heng Industry Group Co Ltd Details 2.19.2 Tai Heng Industry Group Co Ltd Major Business 2.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services 2.19.4 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.19.5 Tai Heng Industry Group Co Ltd Recent Developments/Updates 2.20 Shandong Anxin Pharmaceutical Co Ltd 2.20.1 Shandong Anxin Pharmaceutical Co Ltd Details 2.20.2 Shandong Anxin Pharmaceutical Co Ltd Major Business 2.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services 2.20.4 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.20.5 Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates 3 Competitive Environment: Imatinib Mesylate API by Manufacturer 3.1 Global Imatinib Mesylate API Sales Quantity by Manufacturer (2018-2023) 3.2 Global Imatinib Mesylate API Revenue by Manufacturer (2018-2023) 3.3 Global Imatinib Mesylate API Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Imatinib Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Imatinib Mesylate API Manufacturer Market Share in 2022 3.4.2 Top 6 Imatinib Mesylate API Manufacturer Market Share in 2022 3.5 Imatinib Mesylate API Market: Overall Company Footprint Analysis 3.5.1 Imatinib Mesylate API Market: Region Footprint 3.5.2 Imatinib Mesylate API Market: Company Product Type Footprint 3.5.3 Imatinib Mesylate API Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Imatinib Mesylate API Market Size by Region 4.1.1 Global Imatinib Mesylate API Sales Quantity by Region (2018-2029) 4.1.2 Global Imatinib Mesylate API Consumption Value by Region (2018-2029) 4.1.3 Global Imatinib Mesylate API Average Price by Region (2018-2029) 4.2 North America Imatinib Mesylate API Consumption Value (2018-2029) 4.3 Europe Imatinib Mesylate API Consumption Value (2018-2029) 4.4 Asia-Pacific Imatinib Mesylate API Consumption Value (2018-2029) 4.5 South America Imatinib Mesylate API Consumption Value (2018-2029) 4.6 Middle East and Africa Imatinib Mesylate API Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Imatinib Mesylate API Sales Quantity by Type (2018-2029) 5.2 Global Imatinib Mesylate API Consumption Value by Type (2018-2029) 5.3 Global Imatinib Mesylate API Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Imatinib Mesylate API Sales Quantity by Application (2018-2029) 6.2 Global Imatinib Mesylate API Consumption Value by Application (2018-2029) 6.3 Global Imatinib Mesylate API Average Price by Application (2018-2029) 7 North America 7.1 North America Imatinib Mesylate API Sales Quantity by Type (2018-2029) 7.2 North America Imatinib Mesylate API Sales Quantity by Application (2018-2029) 7.3 North America Imatinib Mesylate API Market Size by Country 7.3.1 North America Imatinib Mesylate API Sales Quantity by Country (2018-2029) 7.3.2 North America Imatinib Mesylate API Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Imatinib Mesylate API Sales Quantity by Type (2018-2029) 8.2 Europe Imatinib Mesylate API Sales Quantity by Application (2018-2029) 8.3 Europe Imatinib Mesylate API Market Size by Country 8.3.1 Europe Imatinib Mesylate API Sales Quantity by Country (2018-2029) 8.3.2 Europe Imatinib Mesylate API Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Imatinib Mesylate API Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Imatinib Mesylate API Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Imatinib Mesylate API Market Size by Region 9.3.1 Asia-Pacific Imatinib Mesylate API Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Imatinib Mesylate API Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Imatinib Mesylate API Sales Quantity by Type (2018-2029) 10.2 South America Imatinib Mesylate API Sales Quantity by Application (2018-2029) 10.3 South America Imatinib Mesylate API Market Size by Country 10.3.1 South America Imatinib Mesylate API Sales Quantity by Country (2018-2029) 10.3.2 South America Imatinib Mesylate API Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Imatinib Mesylate API Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Imatinib Mesylate API Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Imatinib Mesylate API Market Size by Country 11.3.1 Middle East & Africa Imatinib Mesylate API Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Imatinib Mesylate API Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Imatinib Mesylate API Market Drivers 12.2 Imatinib Mesylate API Market Restraints 12.3 Imatinib Mesylate API Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Imatinib Mesylate API and Key Manufacturers 13.2 Manufacturing Costs Percentage of Imatinib Mesylate API 13.3 Imatinib Mesylate API Production Process 13.4 Imatinib Mesylate API Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Imatinib Mesylate API Typical Distributors 14.3 Imatinib Mesylate API Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer

List of Tables
Table 1. Global Imatinib Mesylate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Imatinib Mesylate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Aurobindo Pharma Ltd Major Business
Table 5. Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services
Table 6. Aurobindo Pharma Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Aurobindo Pharma Ltd Recent Developments/Updates
Table 8. Formosa Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 9. Formosa Laboratories Inc Major Business
Table 10. Formosa Laboratories Inc Imatinib Mesylate API Product and Services
Table 11. Formosa Laboratories Inc Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Formosa Laboratories Inc Recent Developments/Updates
Table 13. Cadila Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Cadila Healthcare Ltd Major Business
Table 15. Cadila Healthcare Ltd Imatinib Mesylate API Product and Services
Table 16. Cadila Healthcare Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cadila Healthcare Ltd Recent Developments/Updates
Table 18. Laurus Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Laurus Labs Ltd Major Business
Table 20. Laurus Labs Ltd Imatinib Mesylate API Product and Services
Table 21. Laurus Labs Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Laurus Labs Ltd Recent Developments/Updates
Table 23. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Msn Laboratories Private Ltd Major Business
Table 25. Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services
Table 26. Msn Laboratories Private Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Msn Laboratories Private Ltd Recent Developments/Updates
Table 28. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Intas Pharmaceuticals Ltd Major Business
Table 30. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services
Table 31. Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Intas Pharmaceuticals Ltd Recent Developments/Updates
Table 33. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Zydus Lifesciences Ltd Major Business
Table 35. Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 36. Zydus Lifesciences Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zydus Lifesciences Ltd Recent Developments/Updates
Table 38. Hetero Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Hetero Labs Ltd Major Business
Table 40. Hetero Labs Ltd Imatinib Mesylate API Product and Services
Table 41. Hetero Labs Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hetero Labs Ltd Recent Developments/Updates
Table 43. Shilpa Pharma Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Shilpa Pharma Lifesciences Ltd Major Business
Table 45. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 46. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
Table 48. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Teva Pharmaceutical Industries Ltd Major Business
Table 50. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 51. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 53. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Cipla Ltd Major Business
Table 55. Cipla Ltd Imatinib Mesylate API Product and Services
Table 56. Cipla Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cipla Ltd Recent Developments/Updates
Table 58. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Acebright India Pharma Private Ltd Major Business
Table 60. Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services
Table 61. Acebright India Pharma Private Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 63. Fis Fabbrica Italiana Sintetici Spa Basic Information, Manufacturing Base and Competitors
Table 64. Fis Fabbrica Italiana Sintetici Spa Major Business
Table 65. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services
Table 66. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 68. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Dr Reddys Laboratories Ltd Major Business
Table 70. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services
Table 71. Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 73. Natco Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Natco Pharma Ltd Major Business
Table 75. Natco Pharma Ltd Imatinib Mesylate API Product and Services
Table 76. Natco Pharma Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Natco Pharma Ltd Recent Developments/Updates
Table 78. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 79. Sun Pharmaceutical Industries Ltd Major Business
Table 80. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 81. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 83. Reliance Life Sciences Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Reliance Life Sciences Pvt Ltd Major Business
Table 85. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services
Table 86. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Reliance Life Sciences Pvt Ltd Recent Developments/Updates
Table 88. Zhejiang Jiuzhou Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 89. Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business
Table 90. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 91. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
Table 93. Tai Heng Industry Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 94. Tai Heng Industry Group Co Ltd Major Business
Table 95. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services
Table 96. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Tai Heng Industry Group Co Ltd Recent Developments/Updates
Table 98. Shandong Anxin Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Shandong Anxin Pharmaceutical Co Ltd Major Business
Table 100. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 101. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
Table 103. Global Imatinib Mesylate API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 104. Global Imatinib Mesylate API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Imatinib Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 106. Market Position of Manufacturers in Imatinib Mesylate API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Imatinib Mesylate API Production Site of Key Manufacturer
Table 108. Imatinib Mesylate API Market: Company Product Type Footprint
Table 109. Imatinib Mesylate API Market: Company Product Application Footprint
Table 110. Imatinib Mesylate API New Market Entrants and Barriers to Market Entry
Table 111. Imatinib Mesylate API Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Imatinib Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 113. Global Imatinib Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 114. Global Imatinib Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Imatinib Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Imatinib Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 117. Global Imatinib Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 118. Global Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 119. Global Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 120. Global Imatinib Mesylate API Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Imatinib Mesylate API Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Imatinib Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 123. Global Imatinib Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 124. Global Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 125. Global Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 126. Global Imatinib Mesylate API Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Imatinib Mesylate API Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Imatinib Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 129. Global Imatinib Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 130. North America Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 131. North America Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 132. North America Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 133. North America Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 134. North America Imatinib Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 135. North America Imatinib Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 136. North America Imatinib Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Imatinib Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 139. Europe Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 140. Europe Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 141. Europe Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 142. Europe Imatinib Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 143. Europe Imatinib Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 144. Europe Imatinib Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Imatinib Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 147. Asia-Pacific Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 148. Asia-Pacific Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 149. Asia-Pacific Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 150. Asia-Pacific Imatinib Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 151. Asia-Pacific Imatinib Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 152. Asia-Pacific Imatinib Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Imatinib Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 155. South America Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 156. South America Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 157. South America Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 158. South America Imatinib Mesylate API Sales Quantity by Country (2018-2023) & (Tons)
Table 159. South America Imatinib Mesylate API Sales Quantity by Country (2024-2029) & (Tons)
Table 160. South America Imatinib Mesylate API Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Imatinib Mesylate API Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Imatinib Mesylate API Sales Quantity by Type (2018-2023) & (Tons)
Table 163. Middle East & Africa Imatinib Mesylate API Sales Quantity by Type (2024-2029) & (Tons)
Table 164. Middle East & Africa Imatinib Mesylate API Sales Quantity by Application (2018-2023) & (Tons)
Table 165. Middle East & Africa Imatinib Mesylate API Sales Quantity by Application (2024-2029) & (Tons)
Table 166. Middle East & Africa Imatinib Mesylate API Sales Quantity by Region (2018-2023) & (Tons)
Table 167. Middle East & Africa Imatinib Mesylate API Sales Quantity by Region (2024-2029) & (Tons)
Table 168. Middle East & Africa Imatinib Mesylate API Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Imatinib Mesylate API Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Imatinib Mesylate API Raw Material
Table 171. Key Manufacturers of Imatinib Mesylate API Raw Materials
Table 172. Imatinib Mesylate API Typical Distributors
Table 173. Imatinib Mesylate API Typical Customers
List of Figures
Figure 1. Imatinib Mesylate API Picture
Figure 2. Global Imatinib Mesylate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Imatinib Mesylate API Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Imatinib Mesylate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Imatinib Mesylate API Consumption Value Market Share by Application in 2022
Figure 8. Tablet Examples
Figure 9. Capsule Examples
Figure 10. Global Imatinib Mesylate API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Imatinib Mesylate API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Imatinib Mesylate API Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Imatinib Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Imatinib Mesylate API Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Imatinib Mesylate API Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Imatinib Mesylate API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Imatinib Mesylate API Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Imatinib Mesylate API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Imatinib Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Imatinib Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Imatinib Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Imatinib Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Imatinib Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Imatinib Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Imatinib Mesylate API Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Imatinib Mesylate API Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Imatinib Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Imatinib Mesylate API Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Imatinib Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Imatinib Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Imatinib Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Imatinib Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Imatinib Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Imatinib Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Imatinib Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 52. China Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Imatinib Mesylate API Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Imatinib Mesylate API Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Imatinib Mesylate API Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Imatinib Mesylate API Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Imatinib Mesylate API Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Imatinib Mesylate API Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Imatinib Mesylate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Imatinib Mesylate API Market Drivers
Figure 73. Imatinib Mesylate API Market Restraints
Figure 74. Imatinib Mesylate API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Imatinib Mesylate API in 2022
Figure 77. Manufacturing Process Analysis of Imatinib Mesylate API
Figure 78. Imatinib Mesylate API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • メシル酸ナルトベンのグローバル市場2023：純度98%以上、純度95%～98%、純度95%以下
  • 医薬品用メシル酸サフィナミドのグローバル市場2023：純度≧99%、純度<99%
  • 医薬品用メシル酸エリブリンのグローバル市場2023：純度≧99%、純度<99%
  • イマチニブ製剤のグローバル市場（2023年-2030年）：カプセル、錠剤
  • 世界のメシル酸レンバチニブカプセル市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG10771 )"メシル酸イマチニブAPIのグローバル市場2023：純度≧99%、純度<99%" (英文：Global Imatinib Mesylate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。